Seoul, South Korea

Young-Jin Ham

This inventor holds 1 USPTO granted patent. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Young-Jin Ham. Retrieved from https://idiyas.com/inventor/young-jin-ham-wiubfo96

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Young-Jin Ham: Innovator in Pharmaceutical Chemistry

Introduction

Young-Jin Ham is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry. His innovative work has led to the development of a unique process for synthesizing complex chemical compounds.

Latest Patents

Young-Jin Ham holds a patent for the "Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-{(2-methyl-1H-imidazol-1-yl)methyl}-4H-carbazol-4-one." This process allows for the preparation of pure 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one or a pharmaceutically acceptable salt thereof in high yield. The method involves reacting 1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one with a 2-methylimidazole derivative in an organic solvent or a mixture of an organic solvent and water, utilizing a halosilane compound.

Career Highlights

Young-Jin Ham is currently employed at Hanmi Pharm. Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and excellence in pharmaceutical sciences.

Collaborations

He has collaborated with esteemed colleagues, including Kwang-Ok Lee and Hee-Seock Kim, to further enhance the impact of his research in the industry.

Conclusion

Young-Jin Ham's contributions to pharmaceutical chemistry exemplify the spirit of innovation in the field. His patented processes not only demonstrate his expertise but also pave the way for future advancements in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…